SCHEMBL23618151

SCHEMBL23618151

Nc1nc(-c2ccc3c(c2)=CCCC=3)c(F)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPL P40238 3/20 0.54
▸ CD274 Q9NZQ7 1/20 0.37
▸ ALDH1A1 P00352 5/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ ADORA1 P30542 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ LMNA P02545 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MYC P01106 1/20 0.35
▸ WDR5 P61964 1/20 0.35
▸ SMN1; SMN2 Q16637 4/20 0.34
▸ XBP1 P17861 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ GAA P10253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23618154 0.82 CD274 (0.56) MPLCD274ALDH1A1KDM4EHSD17B10
SCHEMBL23618155 0.82 MAPT (0.44) MPLCD274ALDH1A1KDM4ECYP3A4
SCHEMBL31156391 0.79 MPL (0.69) MPLCD274ALDH1A1KDM4ECYP3A4
SCHEMBL25247416 0.79 MPL (0.69) MPLCD274ALDH1A1KDM4ECYP3A4
SCHEMBL25694595 0.73 MPL (0.61) MPLALDH1A1KDM4ECYP3A4HPGD
SCHEMBL30464966 0.73 MPL (0.66) MPLALDH1A1KDM4ECYP3A4HPGD
SCHEMBL23610359 0.73 MPL (0.57) MPLALDH1A1KDM4ECYP3A4ADORA1
SCHEMBL25280365 0.73 MPL (0.66) MPLALDH1A1KDM4ECYP3A4HPGD
SCHEMBL25695456 0.71 MPL (0.55) MPLCD274ALDH1A1KDM4ECYP3A4
SCHEMBL5313921 0.70 MPL (1.00) MPLHPGDHSD17B10MYCWDR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210205275-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2021-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210205275-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME GAP43, NLN, SMN1; SMN2 MPL 4766/4885CD274 4259/4885ALDH1A1 1731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback